Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ted Kwaks"'
Autor:
Joan E. M. van der Lubbe, Johan W. A. Verspuij, Jeroen Huizingh, Sonja P. R. Schmit-Tillemans, Jeroen T. B. M. Tolboom, Liesbeth E. H. A. Dekking, Ted Kwaks, Börries Brandenburg, Wim Meijberg, Roland C. Zahn, Ramon Roozendaal, Harmjan Kuipers
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Seasonal influenza vaccines are updated almost annually to match the antigenic drift in influenza hemagglutinin (HA) surface glycoprotein. A new HA stem-based antigen, the so-called “mini-HA,” was recently shown to induce cross-protective antibod
Externí odkaz:
https://doaj.org/article/322bfb8a4d904d03bb6ca95c5abe3554
Autor:
Boerries Brandenburg, Wouter Koudstaal, Jaap Goudsmit, Vincent Klaren, Chan Tang, Miriam V Bujny, Hans J W M Korse, Ted Kwaks, Jason J Otterstrom, Jarek Juraszek, Antoine M van Oijen, Ronald Vogels, Robert H E Friesen
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e80034 (2013)
Human monoclonal antibodies have been identified which neutralize broad spectra of influenza A or B viruses. Here, we dissect the mechanisms by which such antibodies interfere with infectivity. We distinguish four mechanisms that link the conserved h
Externí odkaz:
https://doaj.org/article/94c3128c61834b27bb660217681e881d
Autor:
Jort Vellinga, Mark J. G. Bakkers, Dan H. Barouch, Danielle van Manen, Adriaan H. de Wilde, Annemiek Verwilligen, David Zuijdgeest, Roland Zahn, Joan E.M. van der Lubbe, Eric J. Snijder, Jerome Custers, Lucy Rutten, Hanneke Schuitemaker, Frank Wegmann, Zhenfeng Li, Ted Kwaks, Ronald Vogels, Marjolein Kikkert, Annemart Koornneef, Tim J. Dalebout, Sebenzile K. Myeni, Gijs Hardenberg, Rinke Bos, Johannes P. M. Langedijk
Publikováno v:
npj Vaccines, Vol 5, Iss 1, Pp 1-11 (2020)
npj Vaccines
NPJ Vaccines
npj Vaccines, 5(1). NATURE RESEARCH
npj Vaccines
NPJ Vaccines
npj Vaccines, 5(1). NATURE RESEARCH
Development of effective preventative interventions against SARS-CoV-2, the etiologic agent of COVID-19 is urgently needed. The viral surface spike (S) protein of SARS-CoV-2 is a key target for prophylactic measures as it is critical for the viral re
Autor:
Roland Zahn, Mark J. G. Bakkers, Ralph S. Baric, Laurent Pessaint, Timothy M. Caradonna, Galit Alter, Ted Kwaks, John S. Burke, Mathai Mammen, Jingyou Yu, Johan Van Hoof, Bing Chen, Marinela Kirilova, Alex Van Ry, Joseph P. Nkolola, Lisa H. Tostanoski, Johannes P. M. Langedijk, Shivani A. Patel, Shant H. Mahrokhian, Carolin Loos, Kelvin Blade, Makda S. Gebre, Lauren Peter, Katherine McMahan, Douglas A. Lauffenburger, Caroline Atyeo, Rinke Bos, Felix Nampanya, Zhenfeng Li, John D. Ventura, Noe B. Mercado, David R. Martinez, Renita Brown, Catherine Jacob-Dolan, Esther A. Bondzie, Amanda Strasbaugh, Blake M. Hauser, Huahua Wan, Elyse Teow, Hanne Andersen, Jinyan Liu, Frank Wegmann, Jerome Custers, Mark G. Lewis, Ramya Nityanandam, Anthony L. Cook, Danielle van Manen, Aaron G. Schmidt, Stephanie Fischinger, Mehtap Cabus, Gabriel Dagotto, Lucy Rutten, Lori F. Maxfield, Zijin Lin, Sietske K. Rosendahl Huber, Hanneke Schuitemaker, Paul Stoffels, Abishek Chandrashekar, Dan H. Barouch, Jared Feldman, David Zuijdgeest, Xuan He, Serge Zouantchangadou, Kaylee Verrington, Yongfei Cai, Emily Hoffman, Jort Vellinga, R. Keith Reeves
Publikováno v:
Nature
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1-8. For global deployment and pandemic control, a vaccine that requires only a singl
Autor:
Lisa H. Tostanoski, Anthony L. Cook, Lori F. Maxfield, Hanneke Schuitemaker, Joseph P. Nkolola, Marinela Kirilova, Hanne Leth Andersen, John S. Burke, Jerome Custers, Kelvin Blade, Lauren Peter, Mathai Mammen, Ramya Nityanandam, Renita Brown, Frank Wegmann, Bing Chen, Jingyou Yu, Aaron G. Schmidt, Mehtap Cabus, Katherine McMahan, Shant H. Mahrokhian, John D. Ventura, Makda S. Gebre, Noe B. Mercado, Lucy Rutten, Roland Zahn, Jared Feldman, Alex Van Ry, Catherine Jacob-Dolan, Ralph S. Baric, Jinyan Liu, Esther A. Bondzie, Amanda Strasbaugh, Laurent Pessaint, Timothy M. Caradonna, Stephanie Fischinger, Elyse Teow, R. Keith Reeves, Douglas A. Lauffenburger, Mark J. G. Bakkers, Danielle van Manen, Mark G. Lewis, Kaylee Verrington, Rinke Bos, Huahua Wan, Emily Hoffman, Gabriel Dagotto, Caroline Atyeo, Shivani A. Patel, Ted Kwaks, Galit Alter, Blake M. Hauser, Jort Vellinga, Carolin Loos, Johan Van Hoof, Felix Nampanya, Zhenfeng Li, Dan H. Barouch, David Zuijdgeest, Zijin Lin, Johannes P. M. Langedijk, David R. Martinez, Sietske K. Rosendahl Huber, Yongfei Cai, Paul Stoffels, Xuan He, Serge Zouantchangadou, Abishek Chandrashekar
Publikováno v:
Nature
Autor:
Jerome Custers, Johannes P. M. Langedijk, Tim J. Dalebout, Gijs Hardenberg, Sebenzile K. Myeni, Roland Zahn, Eric J. Snijder, Danielle van Manen, Rinke Bos, Adriaan H. de Wilde, Jort Vellinga, Frank Wegmann, Mark J. G. Bakkers, Zhenfeng Li, Dan H. Barouch, Ronald Vogels, Joan E.M. van der Lubbe, Ted Kwaks, David Zuijdgeest, Annemiek Verwilligen, Marjolein Kikkert, Lucy Rutten, Hanneke Schuitemaker, Annemart Koornneef
Development of effective preventative interventions against SARS-CoV-2, the etiologic agent of COVID-19 is urgently needed. The viral surface spike (S) protein of SARS-CoV-2 is a key target for prophylactic measures as it is critical for the viral re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01c42fae113aedc00c3db8373d598e98
https://doi.org/10.1101/2020.07.30.227470
https://doi.org/10.1101/2020.07.30.227470
Autor:
Johan W. A. Verspuij, Petra Mooij, Harmjan Kuipers, Lisanne Tettero, Jeroen Huizingh, Liesbeth Dekking, Daniella Mortier, Jeroen Tolboom, Sonja P. R. Schmit-Tillemans, Hanneke Schuitemaker, Ted Kwaks, Willy M. J. M. Bogers, Gerrit Koopman, Joan E. M. van der Lubbe, Ramon Roozendaal, Boerries Brandenburg, Roland Zahn, Wim Meijberg
Publikováno v:
npj Vaccines, 3(1):25. Nature Publishing Group
npj Vaccines, Vol 3, Iss 1, Pp 1-9 (2018)
NPJ Vaccines
npj Vaccines, Vol 3, Iss 1, Pp 1-9 (2018)
NPJ Vaccines
Seasonal vaccines are currently the most effective countermeasure against influenza. However, seasonal vaccines are only effective against strains closely related to the influenza strains contained in the vaccine. Recently a new hemagglutinin (HA) st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37afb0217a019f93d61a111b27c02f43
https://pure.amc.nl/en/publications/minihemagglutinin-vaccination-induces-crossreactive-antibodies-in-preexposed-nhp-that-protect-mice-against-lethal-influenza-challenge(7ece9426-b1a1-4714-a24c-94e3d26594c7).html
https://pure.amc.nl/en/publications/minihemagglutinin-vaccination-induces-crossreactive-antibodies-in-preexposed-nhp-that-protect-mice-against-lethal-influenza-challenge(7ece9426-b1a1-4714-a24c-94e3d26594c7).html
Autor:
Jaap Goudsmit, C. Ophorst, Ryan M. B. Hoffman, Els C. M. Brinkman-van der Linden, Mandy Jongeneelen, Wouter Koudstaal, Mark J. Kwakkenbos, Esther J. M. Stoop, Ted Kwaks, Jarek Juraszek, Arjen Q. Bakker, Andrew B. Ward, Robert H. E. Friesen, Tim Beaumont, Hergen Spits, Peter Lee, Wenli Yu, Hans J. W. M. Korse, Ian A. Wilson, Gira Bhabha, Damian C. Ekiert, Ronald Vogels, Mark Throsby
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 111(1), 445-450. National Academy of Sciences
The discovery and characterization of broadly neutralizing antibodies (bnAbs) against influenza viruses have raised hopes for the development of monoclonal antibody (mAb)-based immunotherapy and the design of universal influenza vaccines. Only one hu
Autor:
Vincent Klaren, Esther J. M. Stoop, Freek Cox, Eirikur Saeland, Eric Geelen, David Adrianus Theo Zuijdgeest, Bastiaan Smal, Hans J. W. M. Korse, Martin Koldijk, Ted Kwaks, Ronald Vogels, Boerries Brandenburg, Lisanne Tettero, Wouter Koudstaal, Robert Heinz Edward Friesen, Jaap Goudsmit
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Frontiers in immunology, 7. Frontiers Media S.A.
Frontiers in Immunology
Frontiers in immunology, 7. Frontiers Media S.A.
Frontiers in Immunology
Interactions with receptors for the Fc region of IgG (Fc gamma Rs) have been shown to contribute to the in vivo protection against influenza A viruses provided by broadly neutralizing antibodies (bnAbs) that bind to the viral hemagglutinin (HA) stem.
Autor:
Martin H. Koldijk, Samaneh Mashaghi, Jaap Goudsmit, Antoine M. van Oijen, Chan Tang, Ronald Vogels, Boerries Brandenburg, Jarek Juraszek, Ted Kwaks, Jason J. Otterstrom, Robert H. E. Friesen
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 111(48), E5143-E5148. National Academy of Sciences
The ability of antibodies binding the influenza hemagglutinin (HA) protein to neutralize viral infectivity is of key importance in the design of next-generation vaccines and for prophylactic and therapeutic use. The two antibodies CR6261 and CR8020 h